我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

晚期糖基化终末产物对心血管损伤的机制及防治策略(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2017年第2期
页码:
241-245
栏目:
综述
出版日期:
2016-11-25

文章信息/Info

Title:
Underlying mechanisms and preventive strategies of advanced glycation end products in cardiovascular injury
作者:
张仁宇1; 任 超1; 秦兴华1; 李婷婷1; 杨红艳1; 贾 敏2; 张 星1
（第四军医大学：1.航空航天医学系，2.生理学教研室，陕西 西安 710032）
Author(s):
ZHANG Ren-yu1;  REN Chao1;  QIN Xing-hua1;  LI Ting-ting1;  YANG Hong-yan1;  JIA Min2;  ZHANG Xing1
(1.Department of Aerospace Medicine, 2.Department of Physiology, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
晚期糖基化终末产物; 心血管损伤; 羧甲基赖氨酸
Keywords:
advanced glycation end products;  cardiovascular injury;  carboxymethyl-lysine
分类号:
R54
DOI:
-
文献标识码:
A
摘要:
晚期糖基化终末产物（advanced glycosylation end products, AGEs）是糖酮或醛基与蛋白、脂质、氨基酸的自由氨基经不可逆反应所形成的物质，是非酶糖基化反应的最终产物。研究发现在动脉硬化、心肌舒张异常及内皮功能紊乱等心血管疾病中都出现AGEs水平的增加，并且抑制AGEs的产生或作用具有心血管保护作用。因此，AGEs可以作为防治心血管疾病的一个潜在靶点。本文重点综述了AGEs的来源、心血管损伤机制及防治策略。
Abstract:
Advanced glycation end products (AGEs) are a complex group of compounds that are formed when reducing sugar or aldehyde reacts irreversibly in a non-enzymatic manner with free amino in proteins, lipoids or amino acids. Increased level of AGEs has been found in cardiovascular diseases such as arterial stiffening, myocardial relaxation abnormalities and endothelial dysfunction. Furthermore, accumulation of AGEs contributes to changes in the structure and function of cardiovascular system. Thus, it is possible to prevent or cure cardiovascular diseases by inhibition of AGEs. This review mainly summarizes the sources of AGEs, the underlying mechanisms in induction of cardiovascular injury and the preventive strategies.

参考文献/References

[1]Pertynska-Marczewska M,Merhi Z.Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women[J].Reprod Sci,2015,22(7):774-782.
[2]Ott C,Jacobs K,Haucke E,et al.Role of advanced glycation end products in cellular signaling[J].Redox Biol,2014,2:411-429.
[3]Luevano-Contreras C,Chapman-Novakofski K.Dietary advanced glycation end products and aging[J].Nutrients,2010,2(12):1247-1265.
[4]Kalousova M,Zima T.AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers[J].Vnitr Lek,2014,60(9):720-724.
[5]Javed F,Al-Rasheed A,Almas K,et al.Effect of cigarette smoking on the clinical outcomes of periodontal surgical procedures[J].Am J Med Sci,2012,343(1):78-84.
[6]郑 莺，刘建平.糖尿病致冠状动脉粥样硬化的机制[J].心脏杂志,2007,19(3):347-350.
[7]Uribarri J,Woodruff S,Goodman S,et al.Advanced glycation end products in foods and a practical guide to their reduction in the diet[J].J Am Diet Assoc,2010,110(6):911-916.
[8]Sharma C,Kaur A,Thind SS,et al.Advanced glycation End-products(AGEs):an emerging concern for processed food industries[J].J Food Sci Technol,2015,52(12):7561-7576.
[9]Uribarri J,Cai W,Sandu O,et al.Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects[J].Ann N Y Acad Sci,2005,1043:461-466.
[10]Yamagishi S,Fukami K,Matsui T.Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence:A novel marker of vascular complications in high-risk patients for cardiovascular disease[J].Int J Cardiol,2015,185:263-268.
[11]Janda K,Krzanowski M,Gajda M,et al.Vascular effects of advanced glycation end-products:content of immunohistochemically detected AGEs in radial artery samples as a predictor for arterial calcification and cardiovascular risk in asymptomatic patients with chronic kidney disease[J].Dis Markers,2015,2015:153978.
[12]Nenna A,Spadaccio C,Lusini M,et al.Basic and Clinical Research Against Advanced Glycation End Products (AGEs):New Compounds to Tackle Cardiovascular Disease and Diabetic Complications[J].Recent Adv Cardiovasc Drug Discov,2015,10(1):10-33.
[13]Hegab Z,Gibbons S,Neyses L,et al.Role of advanced glycation end products in cardiovascular disease[J].World J Cardiol,2012,4(4):90-102.
[14]Deluyker D,Ferferieva V,Noben JP,et al.Cross-linking versus RAGE: How do high molecular weight advanced glycation products induce cardiac dysfunction?[J].nt J Cardiol,2016,210:100-108.
[15]Lazo M,Halushka MK,Shen L,et al.Soluble receptor for advanced glycation end products and the risk for incident heart failure:The Atherosclerosis Risk in Communities Study[J].Am Heart J,2015,170(5):961-967.
[16]Vlassara H,Fuh H,Makita Z,et al.Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals:a model for diabetic and aging complications[J].Proc Natl Acad Sci U S A,1992,89(24):12043-12047.
[17]Xu B,Chibber R,Ruggiero D,et al.Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products[J].FASEB J,2003,17(10):1289-1291.
[18]Liu J,Yan L,Niu R,et al.Protection effect of endomorphins on advanced glycation end products induced injury in endothelial cells[J].J Diabetes Res,2013,2013:105780.
[19]Bucala R,Makita Z,Vega G,et al.Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency[J].Proc Natl Acad Sci USA,1994,91(20):9441-9445.
[20]Chang JB,Chu NF,Syu JT,et al.Advanced glycation end products(AGEs)in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients[J].Lipids Health Dis,2011,10:228.
[21]Pinkas A,Aschner M.Advanced glycation end-products and their receptors:related pathologies, recent therapeutic strategies and a potential model for future neurodegeneration studies[J].Chem Res Toxicol,2016,29(5):707-714.
[22]Zhou Z,Wang K,Penn MS,et al.Receptor for AGE(RAGE)mediates neointimal formation in response to arterial injury[J]. Circulation,2003,107(17):2238-2243.
[23]梁子介，刘海燕，陈孝文.晚期糖基化终末产物与慢性肾衰竭的研究进展[J].国际泌尿系统杂志,2006(3):395-399.
[24]Corman B,Duriez M,Poitevin P,et al.Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy[J].Proc Natl Acad Sci U S A,1998,95(3):1301-1306.
[25]Nenna A,Nappi F,Avtaar SS,et al.Pharmacologic Approaches Against Advanced Glycation End Products(AGEs)in Diabetic Cardiovascular Disease[J].Res Cardiovasc Med,2015,4(2):e26949.
[26]Candido R,Forbes JM,Thomas MC,et al.A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes[J]. Circ Res,2003,92(7):785-792.
[27]Rowisha M,El-Batch M,El Shikh T,et al.Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks[J].Pediatr Res,2016,doi:10.1038/pr.2016.55.
[28]Choi SY,Chang HJ,Choi SI,et al.Long-term exercise training attenuates age-related diastolic dysfunction: association of myocardial collagen cross-linking[J].J Korean Med Sci,2009,24(1):32-39.
[29]Boor P,Celec P,Behuliak M,et al.Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats[J].Metabolism,2009,58(11):1669-1677.
[30]Goon JA,Aini AH,Musalmah M,et al.Effect of Tai Chi exercise on DNA damage, antioxidant enzymes, and oxidative stress in middle-age adults[J].J Phys Act Health,2009,6(1):43-54.

备注/Memo

备注/Memo:
收稿日期：2016-03-15.
基金项目：国家自然科学基金项目资助(31500932；31500928)
通讯作者：张星，讲师，主要从事心血管保护研究 Email：Lbmed@163.com
作者简介：张仁宇，本科生 Email：firstzry@126.com 共同第一作者：任超，本科生 Email：18109275445@163.com 共同第一作者：贾敏，助教，硕士 Email：108016154@qq.com
更新日期/Last Update: 2016-10-11